Susquehanna International Group, LLP Invitae Corp Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.72 $34,398 - $58,968	-81,900 Reduced 7.33%	1,035,100 $652,000
Q3 2023 Nov 14, 2023	BUY	$0.6 - $1.53 $411,480 - $1.05 Million	685,800 Added 159.04%	1,117,000 $670,000
Q2 2023 Aug 11, 2023	SELL	$1.05 - $1.63 $125,160 - $194,296	-119,200 Reduced 21.66%	431,200 $487,000
Q1 2023 May 16, 2023	SELL	$1.2 - $2.73 $27,960 - $63,609	-23,300 Reduced 4.06%	550,400 $743,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $781,641 - $1.65 Million	-457,100 Reduced 44.34%	573,700 $1.07 Million

Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $1.2 Million - $5.45 Million	631,800 Added 158.35%	1,030,800 $2.54 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.